Skip to Content
You are currently on the new version of our website. Access the old version .

1 Result Found

  • Review
  • Open Access
30 Citations
17,973 Views
21 Pages

31 July 2020

Memantine, an N-methyl-d-aspartate (NMDA) receptor antagonist approved for treating Alzheimer’s disease, has a good safety profile and is increasingly being studied for possible use in a variety of non-dementia psychiatric disorders. There is a...

(This article belongs to the Special Issue NMDA Receptor in Health and Diseases)